What? MannKind posts best-ever quarter of inhaled-insulin sales - STAT

What? MannKind posts best-ever quarter of inhaled-insulin sales - STAT

STAT Plus: Wait … what? Mannkind posts best-ever quarter of inhaled insulin product sales

By ADAM FEUERSTEIN

SANOFI

Mannkind delivered strong financial results for the fourth quarter — noteworthy for the best-ever quarterly sales of the inhaled insulin, Afrezza.

READ MORE